Header Logo

Connection

James Papin to Schistosoma mansoni

This is a "connection" page, showing publications James Papin has written about Schistosoma mansoni.
Connection Strength

0.286
  1. Sm-p80-based vaccine trial in baboons: efficacy when mimicking natural conditions of chronic disease, praziquantel therapy, immunization, and Schistosoma mansoni re-encounter. Ann N Y Acad Sci. 2018 08; 1425(1):19-37.
    View in: PubMed
    Score: 0.157
  2. Fifteen Years of Sm-p80-Based Vaccine Trials in Nonhuman Primates: Antibodies From Vaccinated Baboons Confer Protection in vivo and in vitro From Schistosoma mansoni and Identification of Putative Correlative Markers of Protection. Front Immunol. 2020; 11:1246.
    View in: PubMed
    Score: 0.045
  3. Chronic whipworm infection exacerbates Schistosoma mansoni egg-induced hepatopathology in non-human primates. Parasit Vectors. 2020 Feb 28; 13(1):109.
    View in: PubMed
    Score: 0.044
  4. Sm-p80-based schistosomiasis vaccine: double-blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission-blocking efficacy. Ann N Y Acad Sci. 2018 08; 1425(1):38-51.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.